Getein Biotech Inc (603387) - Total Liabilities

Latest as of March 2026: CN¥765.68 Million CNY ≈ $112.04 Million USD

Based on the latest financial reports, Getein Biotech Inc (603387) has total liabilities worth CN¥765.68 Million CNY (≈ $112.04 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Getein Biotech Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Getein Biotech Inc - Total Liabilities Trend (2012–2025)

This chart illustrates how Getein Biotech Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 603387 current and non-current assets.

Getein Biotech Inc Competitors by Total Liabilities

The table below lists competitors of Getein Biotech Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Guizhou Guihang Automotive Components Co Ltd SHG:600523	China	CN¥865.89 Million
Alligo AB Series B ST:ALLIGO-B	Sweden	Skr5.91 Billion
New Found Gold Corp V:NFG	Canada	CA$18.61 Million
Sino-High (China) Co. Ltd. SHE:301076	China	CN¥82.10 Million
Tourism Finance Corporation of India Limited NSE:TFCILTD	India	Rs10.57 Billion
Zhang Xiaoquan Inc. SHE:301055	China	CN¥396.64 Million
Covenant Logistics Group, Inc. NYSE:CVLG	USA	$592.89 Million
Grupo Supervielle S.A. B BA:SUPV	Argentina	AR$5.10 Trillion

Liability Composition Analysis (2012–2025)

This chart breaks down Getein Biotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Getein Biotech Inc to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.21	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.27	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.21	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Getein Biotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Getein Biotech Inc (2012–2025)

The table below shows the annual total liabilities of Getein Biotech Inc from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥896.55 Million ≈ $131.19 Million	-9.11%
2024-12-31	CN¥986.42 Million ≈ $144.34 Million	-4.27%
2023-12-31	CN¥1.03 Billion ≈ $150.78 Million	+1.73%
2022-12-31	CN¥1.01 Billion ≈ $148.21 Million	+17.24%
2021-12-31	CN¥863.90 Million ≈ $126.42 Million	+24.13%
2020-12-31	CN¥695.95 Million ≈ $101.84 Million	+113.49%
2019-12-31	CN¥325.98 Million ≈ $47.70 Million	+74.11%
2018-12-31	CN¥187.23 Million ≈ $27.40 Million	+57.50%
2017-12-31	CN¥118.87 Million ≈ $17.39 Million	+30.45%
2016-12-31	CN¥91.13 Million ≈ $13.33 Million	+53.21%
2015-12-31	CN¥59.48 Million ≈ $8.70 Million	+44.16%
2014-12-31	CN¥41.26 Million ≈ $6.04 Million	-41.41%
2013-12-31	CN¥70.42 Million ≈ $10.31 Million	+43.27%
2012-12-31	CN¥49.15 Million ≈ $7.19 Million	--

About Getein Biotech Inc

SHG:603387 China Medical Devices

Market Cap

$699.08 Million

CN¥4.78 Billion CNY

Market Cap Rank

#10666 Global

#2910 in China

Share Price

CN¥9.42

Change (1 day)

-0.63%

52-Week Range

CN¥7.52 - CN¥10.65

All Time High

CN¥21.49